Continuing Medical Education
Medical Crossfire®: Translating Evidence to Clinical Practice in Early-Stage HR+, HER2– Breast Cancer
Expiration Date: 2026-03-17
The Inaugural Hawaii Breast Cancer: A Multidisciplinary Case-Based Conference
Expiration Date: 2026-02-28
42nd Annual CFS: Chemotherapy Foundation Symposium®: Innovative Cancer Therapy for Tomorrow
Expiration Date: 2026-01-31
Medical Crossfire®: Improving Survival in HR-Positive HER2-Negative Metastatic Breast Cancer – Advances in Selective Estrogen Receptor Targeting Therapies
Expiration Date: 2025-12-24
Community Practice Connections™: Case Discussions in TNBC… Navigating the Latest Advances and Impact of Disparities in Care
Expiration Date: 2025-12-23
Community Practice Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2- Breast Cancer
Expiration Date: 2025-12-20
43rd Annual Miami Breast Cancer Conference®
Community Practice Connections™: Navigating Early-Stage HR+/HER2‒- Breast Cancer – Clinical Developments and Innovative Treatments
Expiration Date: 2025-11-27
2nd Annual Hawaii Cancer Conference
Community Practice Connections™: 23rd Annual International Congress on the Future of Breast Cancer West
Expiration Date: 2025-09-30
Inaugural Brain & Spine Metastases Conference: Evolving Practice and Emerging Therapies
23rd Annual School of Breast Oncology
School of Breast Oncology® (SOBO) Slide & Lecture Library
PER Postgame™: Updates from ANNA in the Management of IgA Nephropathy
Expiration Date: 2026-06-30
(CME Track) The Neural Frontier: Mapping Neurostimulation Across the DED Patient Spectrum for Refractive Surgery
Expiration Date: 2026-03-31
(CME Track) Expanding Horizons in Toric IOLs: Translating Technological Advances Into Improved Patient Outcomes
Expiration Date: 2026-03-31
EnVision Summit
Asembia Specialty Pharmacy Day of Education 2025
Expiration Date: 2025-11-07
Shaping the Future of Generalized Myasthenia Gravis Management: A Focus on Novel Treatment Approaches
Expiration Date: 2026-08-01
Expert Insights on the Horizon of HER2-Directed Therapy
Expiration Date: 2026-08-01
VMAT2 Inhibitors for Long-Term Success in Tardive Dyskinesia
Expiration Date: 2026-07-23
